Linda B. Huber

What do you focus on?

I focus on prosecuting biotechnology and life sciences patents, counseling clients on their patent portfolios and prosecution strategies, conducting due diligence of patent portfolios in corporate transactions and patent license agreements and advising clients on patent related license provisions.

Patent Prosecution

Particular areas I focus on include cancer therapeutics, gene therapy, stem cells, gastrointestinal diseases, inflammatory conditions, neurological diseases, diagnostics and nutritional products.

Client Counseling

Through my understanding of my clients’ needs and goals, I develop and implement strategies to manage and expand their patent portfolios. I also help them understand the implications of licensing terms.

What do you see on the horizon?

I believe that the Federal Circuit will refine the definition of patent-eligible subject matter in favor of patentees.

Presentations

• “Guiding Inventors Through the Process,” Cedars-Sinai Tech Transfer Office, Los Angeles, CA, May 8, 2018
• “Great Expectations: Managing Faculty and Inventors,” 2017 AUTM Western Region Meeting, Santa Clara, CA, October 12, 2017
• “The New World in US Biotech,” The Chartered Institute of Patent Attorneys Webinar, March 2016
• “Biotech Claims Drafting,” The Chartered Institute of Patent Attorneys Seminar, October 2014

Publications

• “License Lessons: Don’t overlook key elements in patent-related licensing agreements,” GC California, Nov./Dec. 2009. (Co-author)